Physician profile
John Michael Guest
NPI 1235796780
$3,294.36
in general payments reported to CMS, 2019-2025
17 companies · $544 in 2025
The $544 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $124 · 2021: $322 · 2022: $274 · 2023: $1,181 · 2024: $849 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,567 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,567.17 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $807.63 | 2021-2025 | Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol, Clareon |
| Bausch & Lomb Americas INC. | $614.77 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Regeneron Healthcare Solutions, INC. | $362.92 | 2024-2025 | Eylea Hd, Eylea |
| New World Medical,INC. | $328.59 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $244.83 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $181.37 | 2022-2025 | Omni Surgical System |
| Rxsight INC | $176.85 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Sun Pharmaceutical Industries INC. | $159.84 | 2023 | Cequa |
| Allergan, INC. | $141.43 | 2020-2021 | |
| Dompe US, INC. | $46.46 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $45.12 | 2023 | Iolmaster 700 |
| Oyster Point Pharma, INC. | $44.47 | 2024 | Tyrvaya |
| Genentech USA, INC. | $41.97 | 2024 | Vabysmo |
| Carl Zeiss Meditec, INC. | $36.11 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.31 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $21.10 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $16.59 | 2024 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Guest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.